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cluster 5 were resistant to metronidazole whereas 78% of
the strains in cluster 6 were susceptible to both antibiotics.
Conclusion: These results indicate that clinical Heli-
cobacter pylori strains in terms of antibiotic resistance are
highly diverse. It seems the characteristics of the resistant
and susceptible strains can be predicted by clustering of
strains using RAPD-PCR proﬁling.
doi:10.1016/j.ijid.2008.05.276
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Background: Pseudomonas aeruginosa (PA) is an impor-
tant nosocomial pathogen causing a wide spectrum of
infections and leading to substantial morbidity and mor-
tality. In order to apply optimal therapeutic guidelines
physicians must be aware of recent resistance surveillance,
and epidemiological data. The main objective was to deter-
mine antimicrobial susceptibility of PA isolates in order to
assist the guidelines for empirical regimens and infection
control measures.
Methods: From April 2003 - April 2007, 1446 PA iso-
lates were collected in Centro Hospitalar de Coimbra.
Nosocomial isolates (N= 907) and ambulatory ones (N = 539)
were obtained from sputum (41.2%), urine (24.2%), exu-
dates (14.2%), blood (4.6%) and other sources (15.8%).
They were identiﬁed with API32GN (BioMe´rieux) and
MicroScan WalkAway (Dadebehring) and susceptibility pat-
terns were determined with these panels. Susceptibilities to
Piperacillin (PIP), Piperacillin plus Tazobactam (TZP), Aztre-
onam (AZT), Ceftazidime (CAZ), Imipenem (IP), Meropenem
(MP), Amikacin (AMK), Gentamicin (GN), and Ciproﬂoxacin
(CIP) were guideline by CLSI.
Results: Overall, MP was the best agent (88.0%), followed
by TZP (87.6%), AMK (86.4%), PIP (85.2%), CAZ (82.5%), IP
(79.9%), AZT (79.5%), GN (69.2%) and CIP (66.3%). Nosoco-
mial isolates responded to TZP (82.6%), AMK (82.5%), MP
(81.7%), PIP (79.4%), CAZ (75.5%), AZT (71.4%), IP (70.9%),
GN (62.6%), and CIP (60.5%). Ambulatory isolates presented
susceptibility superior to 90%, except for GN (80.1%) and
CIP (76.1%). During these years the susceptibilities to most
important beta lactams (IP, MP and CAZ) had diminished;
activity of IP decreased 5.9%, CAZ 4.8%, and MP 3.6%.
Conclusion: Appropriate empirical treatments based on
knowledge of particular resistance patterns are important
determinants of the success of treatment, therefore stud-
ies of surveillance can be helpful in ﬁght to control the
development and spread of resistance.
doi:10.1016/j.ijid.2008.05.277
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Background: Several antibiotic combinations are being
used for treatment of brucellosis in endemic regions. The
purpose of this study was to evaluate the antibacterial sus-
ceptibility of several common antibiotics which are used for
treatment of brucellosis.
Methods: From May to October 2007, blood cultures from
26 cases of brucellosis were positive for brucella mellitensis.
Susceptibility testing were performed with using gen-
tamicin, streptomycin, ciproﬂoxacin, oﬂoxacin,doxycycline,
cotrimoxazole, rifampin and the results were recorded.
Results: All isolates were susceptible to gentamicin,
streptomycin, Ciproﬂoxacin, oﬂoxacin, doxycycline but
resistance to rifampin and Cotrimoxazole.
Conclusion: The results show that resistance of brucella
mellitensis to rifampin and cotrimoxazole are being devel-
oped in endemic regions. Attempts to ﬁnd out a regimen
free of these agents are recommended.
doi:10.1016/j.ijid.2008.05.278
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Background: ESBL producing GNB causing blood stream
infections (BSI), skin and soft tissue (SSTI) and respiratory
tract infection (RTI) are widely prevalent in Indian medical
centers. We compared the in-vitro activity of ﬁve com-
monly used antimicrobials to treat such infections against
the recently introduced carbapenem - ertapenem (ERT).
Methods: From a collection of 776 clinically signif-
icant isolates prospectively collected (2005—2007) from
seven medical centers, 238 GNB isolates (Escherichia coli
[EC], = 122, Klebsiella spp. [KS], = 107 and Enterobac-
ter spp. [ES] = 9) obtained from RTI (n = 75), BSI (n = 74),
SSTI (n = 70) and urinary tract (n = 19) were tested. ESBL
screen was performed by disc diffusion using cefotaxime
(CTX) and ceftazidime (CZD), conﬁrmed using CTX and
CZD discs with and without clavulanic acid and Etest
ESBL strips. Antimicrobial resistance to levoﬂoxacin (LEV),
amikacin (AMK), piperacillin/tazobactam (P/T), imipenem
(IMP), meropenem (MER) and ERT was determined by agar
dilution and Etest. Isolates were consideredmulti-drug resis-
tant (MDR), if resistant to >2 classes. Polymerase Chain
Reaction (PCR) was done to determine beta lactamases
(bla)TEM, SHV and CTX-M among 120 isolates.
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Results: In this study, 221(93%) GNB were conﬁrmed ESBL
producers (range between centers, 74 to 99%) of which 94%
were nosocomial in origin. ESBL in intensive care unit (ICU)
and non-ICU patients was 86% and 98% respectively. Among
ESBLs in ICU, 13.5% were community acquired. Resistance
to LEV was 73.3% > P/T 27.3% and >AMK 12.3%. No resis-
tance to IMP and MER seen. Overall 61% were MDR. Four KS
(1.7%) isolates were resistant to ERT. PCR showed blaCTX-
M in 73%, blaTEM in 56% and blaSHV in 38%. Multiple genes
were present in 60%.
Conclusion: Prevalence of ESBL among GNB causing infec-
tions continues to be high in Indian medical centers. ERT
shows good activity equivalent to the tested Group 2 car-
bapenems and may be considered for treatment of such
infections.
doi:10.1016/j.ijid.2008.05.279
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Objectives: MacConkey agar with ceftazidime (CMAC)
was used for early detection of extended spectrum beta-
lactamase(ESBL) for clinical sample received from ICU.
Methods: A total of 374 clinical samples were received
from ICU in the Dept. of Microbiology. Along with Mac-
Conkey agar and Blood agar, the samples were processed on
MacConkey agar with ceftazidime (1mg/L) for provisional
detection of ESBL isolates. Lactose -fermenting colonies on
MacConkey agar with ceftazidime(CMAC) were provisionally
detected as ESBL producing isolates. These isolates were
identiﬁed by standard methods. Presence of ESBL was deter-
mined by CLSI method (cefotaxime and ceftazidime disks
with and without clavulinic acid).
Results: 128 isolates showed growth on CMAC of which
50 were lactose fermenters. 31 isolates were identiﬁed as
E.coli and 19 as K.pneumoniae. All the 50 isolates were
identiﬁed as conﬁrmed ESBL producers.
Conclusion: Compared to phenotypic identiﬁcation of
ESBL producers, CMAC helps in early detection ESBLs which
can be very useful from treatment point of view. Since in
our hospital we have about 60% of ICU patients growing ESBL
producers, this early detection helps the intensivist to start
anti-ESBL therapy.
doi:10.1016/j.ijid.2008.05.280
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Background: Indiscriminate use of beta-lactam antibi-
otics has resulted in emergence of AmpC Beta-lactamases.
Considering the lack of comprehensive studies from India
the present study was undertaken to detect and character-
ize AmpC Beta-lactamases in clinical isolates of Escherichia
coli and Klebsiellaspp.
Methods: One hundred non-repeat clinical isolates each
of Escherichia coli and Klebsiella spp recovered from pus,
urine, blood and sputum, were collected from various hos-
pitals of Delhi. These were screened for susceptibility to
cefoxitin (30g) by disc diffusion method. The screen pos-
itive isolates were subjected to Modiﬁed 3 Dimensional
test (M3D), AmpC disk tests 1 and 2 and Inhibitor (Boronic
acid) based detection method. AmpC positive isolates were
subjected to Polymerase chain reaction (PCR) using family
speciﬁc primers and also tested for production of ESBLs and
inducible AmpC Beta-lactamases.
Results: 34/100 (34%) of Escherichia coli and 21/100
(21%) of Klebsiella spp. were resistant to cefoxitin. Of the
screen positive isolates 12 (35%) of Escherichia coli, and 5
(24%) of Klebsiella spp. were positive for AmpC by various
phenotypic tests. Out of the AmpC positive isolates as many
as 8/12 of Escherichia coli and 3/5 of Klebsiella isolates
were positive for ESBLs. In 3/12 (25%) of Escherichia coli
and 3/5 (60%) of Klebsiella isolates AmpC were inducible.
PCR identiﬁed the AmpC of Escherichia coli as MIR/ACT-
I and CIT types. Amongst Klebsiella isolates, the AmpC
were found to be of MIR/ACTI, CIT, FOX and DHA fami-
lies.
Conclusion: The incidence of AmpC production was
higher (12%) in Escherichia coli than in Klebsiella (5%) iso-
lates. However, co-production of ESBLs was much higher in
Klebsiella (60%) than in Escherichia coli (25%) isolates. The
AmpC Beta-lactamases in Indian isolates were of common
families reported from different parts of the world.
doi:10.1016/j.ijid.2008.05.281
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Objectives: Urinary tract infections (UTI) are one of the
most common infectious diseases diagnosed in outpatients
and also constitutes the most common nosocomial infection
in many hospitals. Escsherichia coli remains the principal
causative pathogen of UTIs both in outpatients and inpa-
tients. In this study it was aimed to compare the resistance
patterns of E. coli strains reported to be isolated from urine
